FDA Clearance Tracker · P220021-S006
DETOUR System
Last checked: Nov 20, 2026Latest source record: Oct 9, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Oct 9, 2025
Approved
Time to decision
42 days
Received Aug 28, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P220021-S006
- Device name
- DETOUR System
- Applicant
- Endologix, LLC
- Applicant location
- Santa Rosa, CA
- Received
- Aug 28, 2025
- Decided
- Oct 9, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P220021
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
a manufacturing site located at Endologix, LLC at 3910 Brickway Blvd., Santa Rosa, CA 95403 for manufacturing the TORUS Stent Graft System and associated manufacturing changes and for an alternate contract sterilizer for the TORUS Stent Graft System located at Steris Isomedix Services at 43425 Business Park Drive, Temecula, CA 92590
Source documents
Other decisions for Endologix, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- DETOUR SystemBreakthroughPMA
P220021 · Decided Jun 7, 2023 · 239 days after receipt
Device type: Stent graft, bypass, superficial femoral artery (QWM) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.